Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer

We conducted a prospective, observational study of aspirin and COX-2 inhibitor use and survival in stage III colon cancer patients enrolled in an adjuvant chemotherapy trial. Among 799 eligible patients, aspirin use was associated with improved recurrence-free survival (RFS) (multivariable hazard ra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Ng, Kimmie, Meyerhardt, Jeffrey A., Chan, Andrew T., Sato, Kaori, Chan, Jennifer A., Niedzwiecki, Donna, Saltz, Leonard B., Mayer, Robert J., Benson, Al B., Schaefer, Paul L., Whittom, Renaud, Hantel, Alexander, Goldberg, Richard M., Venook, Alan P., Ogino, Shuji, Giovannucci, Edward L., Fuchs, Charles S.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Brief Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4271076/
https://ncbi.nlm.nih.gov/pubmed/25432409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju345
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados